Arslan Fatma, Timurhan Yağmur Gizem, Doğan Mülazımoğlu Deniz, Öz Miraç, Gürün Kaya Aslıhan, Erol Serhat, Çiledağ Aydın, Kaya Akın
Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Türkiye
Thorac Res Pract. 2025 Apr 30;26(3):115-124. doi: 10.4274/ThoracResPract.2024.24047. Epub 2025 Jan 20.
Composite Model for End-Stage Liver Disease (MELD), an adapted version of the model score excluding international normalised ratio (MELD-XI), was reported to predict outcomes in patients with organ failure. Aim of study was to evaluate the prognostic significance of the MELD-XI score and compare it with the Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation 2 (APACHE 2) scores in patients admitted to the intensive care unit (ICU) for respiratory failure.
Out of 822 patients with respiratory failure between September 2020 and June 2023, a total of 727 patients with etiologies of chronic obstructive pulmonary disease exacerbation, cardiogenic pulmonary edema, pulmonary thromboembolism, pneumonia, bronchiectasis, kyphoscoliosis, neuromuscular diseases, obesity hypoventilation syndrome, and diffuse parenchymal lung disease were included.
A statistically significant correlation was found between MELD-XI, SOFA, and APACHE 2 scores. The cutoff value of the MELD-XI score was 11 on receiver operating characteristic analysis, indicating a higher risk of mortality in patients with a score of 11 or above. The APACHE 2 and SOFA scores of the MELD-XI ≥11 group were found to be higher and the Glasgow Coma Scale were lower than the MELD-XI <11 group. MELD-XI ≥11 was associated with an increased risk of mortality in overall [Hazard ratio (HR): 4.1, 95% confidence interval (CI): 2-6.4, < 0.001] and subgroups with different etiologies in Cox regression analysis. In the multivariate analysis, MELD-XI was the most important independent variable indicating an increased risk of mortality, regardless of etiology (HR: 2.4, 95% CI: 2.0-2.5, < 0.001).
MELD-XI is an important marker of ICU mortality in patients with respiratory failure due to different etiologies and is as effective as the SOFA and APACHE 2 in predicting mortality.
据报道,终末期肝病综合模型(MELD)的一个改良版本,即排除国际标准化比值的模型评分(MELD-XI),可预测器官衰竭患者的预后。本研究的目的是评估MELD-XI评分的预后意义,并将其与入住重症监护病房(ICU)治疗呼吸衰竭患者的序贯器官衰竭评估(SOFA)和急性生理与慢性健康状况评估Ⅱ(APACHE 2)评分进行比较。
在2020年9月至2023年6月期间的822例呼吸衰竭患者中,共纳入727例病因包括慢性阻塞性肺疾病急性加重、心源性肺水肿、肺血栓栓塞、肺炎、支气管扩张、脊柱后凸侧弯、神经肌肉疾病、肥胖低通气综合征和弥漫性肺实质疾病的患者。
MELD-XI、SOFA和APACHE 2评分之间存在统计学显著相关性。在受试者工作特征分析中,MELD-XI评分的截断值为11,表明评分11及以上的患者死亡风险更高。发现MELD-XI≥11组的APACHE 2和SOFA评分更高,格拉斯哥昏迷量表评分低于MELD-XI<11组。在Cox回归分析中,MELD-XI≥11与总体[风险比(HR):4.1,95%置信区间(CI):2 - 6.4,P<0.001]及不同病因亚组的死亡风险增加相关。在多变量分析中,无论病因如何,MELD-XI都是表明死亡风险增加的最重要独立变量(HR:2.4,95%CI:2.0 - 2.5,P<0.001)。
MELD-XI是不同病因所致呼吸衰竭患者ICU死亡率升高的重要标志物,在预测死亡率方面与SOFA和APACHE 2同样有效。